Hologic (HOLX) Tops Q3 EPS by 37c, Revenues Beat; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks gain, oil prices slide
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Hologic Announces Financial Results for Third Quarter of Fiscal 2020
July 29, 2020 4:01 PM EDTRevenue of $822.9 Million Declines 3.5% due to Cynosure Divestiture, 3.1% in Constant Currency
Organic Revenue Increases 7.7%, 8.1% in Constant Currency, as Strong Sales of COVID Tests Offset Declines in Other Businesses
Company Posts GAAP Diluted EPS of $0.53, Non-GAAP Diluted EPS of $0.75
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today the Companys financial results for the fiscal third quarter ended June 27, 2020.
Our strong third quarter financial results reflect the incredible contributions the Hologic team is making in the fight against the... More
